Annual report pursuant to Section 13 and 15(d)

Income Tax Expense (Tables)

v3.3.1.900
Income Tax Expense (Tables)
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit (Provision)

The Company’s income tax benefit/(provision) is as follows:

 

    Years Ended December 31  
    2015     2014  
Current   $ 269,344     $ 1,295,979  
Deferred     3,795,104     $ 132,379  
Change in Valuation Allowance     (3,795,104 )   $ (1,428,358 )
Income Tax Benefit   $ 269,344     $ -  

Components of Deferred Tax Assets and Related Valuation Allowances

The principle components of the deferred tax assets and related valuation allowances as of December 31, 2015 and 2014 are as follows:

 

    Years Ended December 31  
    2015     2014  
Reserves and other   $ 2,506,000     $ 684,830  
Net operating loss carry-forwards     20,728,000       18,754,066  
Valuation Allowance     (23,234,000 )     (19,438,896 )
Net   $ -     $ -  

Reconciliation of Income Taxes Using Statutory U.S. Income Tax Rate and Benefits from Income Taxes

The reconciliation of income taxes using the statutory U.S. income tax rate and the benefit from income taxes for the years ended December 31, 2015 and 2014 are as follows:

 

    Years Ended December 31  
    2015     2014  
Statutory U.S. Federal Income Tax Rate     (35.0 )%     (35.0 )%
New Jersey State income taxes, net of U.S.                
 Federal tax effect     (6.0 )%     (5.9 )%
Benefit from sale of New Jersey NOL     (2.9 )%     0.0 %
Change in Valuation Allowance     41.0 %     40.9 %
Net     (2.9 )%     0.0 %